Discontinuation report CIPRO
| Report ID | 32228 |
| Drug Identification Number | 02155958 |
| Brand name | CIPRO |
| Common or Proper name | Ciprofloxacin |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-08-15 |
| Actual discontinuation date | 2018-08-09 |
| Remaining supply date | 2018-08-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2018-10-03 | French | Compare |
| v9 | 2018-10-03 | English | Compare |
| v8 | 2018-08-09 | French | Compare |
| v7 | 2018-08-09 | English | Compare |
| v6 | 2018-08-08 | French | Compare |
| v5 | 2018-08-08 | English | Compare |
| v4 | 2018-02-22 | French | Compare |
| v3 | 2018-02-22 | English | Compare |
| v2 | 2017-12-08 | French | Compare |
| v1 | 2017-12-08 | English | Compare |
Showing 1 to 10 of 10